ALBA, CSIC AND ALIBAVA DEVELOP AN X-RAY DETECTOR

A team of researchers and engineers of the ALBA Synchrotron has collaborated with members of the company Alibava Systems and the Institute of Microelectronics of Barcelona (IMB-CNM CSIC) to develop a radiation detector aimed at measuring the intensity of the beam with high precision when performing an experiment at a synchrotron facility. This new detector enables a correct development of the experiment, ensuring the quality of the obtained data and reducing the time of the experiment.

Read more…

ENANTIA USES ALBA’S X-RAYS TO DETECT CRYSTALLINE IMPURITIES IN DRUG PRODUCTS

ENANTIA is a private company dedicated to research in organic synthesis and solid forms for the pharmaceutical and fine chemical industries.

Read more…

ALBA HOSTS A WORKSHOP ABOUT FUNDING AND INVESTMENT

The Catalan Foundation for Research and Innovation (FCRi) is promoting the EDI program (Innovation Teams) to enhance the relationship between research and business sectors. The ALBA Synchrotron, one of the entities joining the EDI program, has hosted the second workshop on investment topics.

Read more…

MORE THAN 30 COMPANIES ATTENDED THE ALBA INDUSTRY WORKSHOP

Renowned companies working in the area of Chemistry and Materials Science, like CEPSA, ERCROS or AC MARCA group, were among the attendees.

Read more…

CRYSFORMA CHARACTERIZES POLYMORPHS FOR THE PHARMACEUTICAL INDUSTRY AT THE ALBA SYNCHROTRON

CRYSFORMA, a unit from the Institute of Chemical Research of Catalonia (ICIQ) managed by Dr. Jordi Cerón, provides complete scientific support to the pharmaceutical and fine chemistry industry in the field of pharmaceutical solid state development. CRYSFORMA is currently applying its expertise to use the ALBA synchrotron facilities in its projects in the area of polymorphism.

Read more…